EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inhibition of PHB1/PHB2 suppresses atherosclerotic plaque formation by interrupting PI3K/AKT/mTOR signaling

Mei Li, Xiaoyan Hu, Xinxin Hu, Fuhua Gao, Ying Cui, Xiaoqing Wei, Yuanhua Qin, Xiaohua An, Ying Zhao, Ying Gao iD

PLOS ONE · 2025

DOI: 10.1371/journal.pone.0320509 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2025. Verfasst von Mei Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, College of Basic Medical Sciences, Dalian Medical University, Dalian, China. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-akt, Phosphatidylinositol 3-Kinases, TOR Serine-Threonine Kinases, Signal Transduction. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prohibitin 1 (PHB1) and prohibitin 2 (PHB2) are highly conserved proteins belonging to the stomatin-prohibitin flotillin-HflC/K (SPFH) protein superfamily. They are ubiquitously expressed and implicated in the regulation of cell proliferation, migration, and survival. However, the expression and biological functions of PHB1/PHB2 in atherosclerosis (AS) remain unclear. In the present study, an enzyme-linked immunosorbent assay was used to detect PHB1/PHB2 expression in the serum of patients with hyperlipidemia. The potential effect and mechanism of PHB1/PHB2 in apolipoprotein E-deficient ( ApoE −/− ) mice were also investigated. shRNA-PHB1 and shRNA-PHB2 lentiviruses were engineered and tail vein-injected into ApoE −/− mice fed a high-fat diet. IL-8, a proatherogenic cytokine, was used as an inducer in vitro . The effects of a PHB1/PHB2 knockdown on vascular smooth muscle cell (VSMC) proliferation, migration, and autophagy and endothelial cell (EC) adhesion were evaluated using methyl thiazolyl tetrazolium (MTT), Transwell migration, Boyden chamber, and monocyte adhesion assays, as well as transmission electron microscopy. Compared with the healthy subjects, PHB1/PHB2 expression was elevated in the serum of patients with hyperlipidemia. Animal experiments showed that downregulation of PHBs reduced the area of atherosclerotic lesions, and the expression of cyclinD1, MMP9, and LC3. In addition, in vitro experiments showed that downregulating PHB1/PHB2 expression under inflammatory stimulation reduced the adhesion, proliferation, migration, and autophagy of ECs and VSMCs by inhibiting the PI3K/Akt/mTOR pathway activation. Collectively, our findings showed that PHBs are activly associated with AS progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesTOR Serine-Threonine KinasesSignal TransductionPlaque, AtheroscleroticRepressor ProteinsProhibitinsAnimalsHumansMiceMaleCell ProliferationCell MovementFemaleHyperlipidemiasMuscle, Smooth, VascularAutophagyAtherosclerosisMyocytes, Smooth MuscleMiddle AgedMice, Inbred C57BL

Substanzen

ProhibitinsProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesTOR Serine-Threonine KinasesPHB2 protein, humanRepressor ProteinsPHB protein, humanPhb2 protein, mouseMTOR protein, human

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Biology, College of Basic Medical Sciences, Dalian Medical University, Dalian, China.
  • Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Liaoning Provincial Core Lab of Medical Molecular Biology, Dalian Medical University, Dalian, China.
  • Molecular Medicine Laboratory, Dalian Medical University, Dalian, China.
  • Department of Parasite, College of Basic Medical Sciences, Dalian Medical University, Dalian, China.
  • Clinical Laboratory, Dalian Central Hospital, Dalian, China.

ORCID-Profile: Ying Gao

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Li, M., Hu, X., Hu, X., Gao, F., Cui, Y., Wei, X., Qin, Y., An, X., Zhao, Y., & Gao, Y. (2025). Inhibition of PHB1/PHB2 suppresses atherosclerotic plaque formation by interrupting PI3K/AKT/mTOR signaling. PLOS ONE. https://doi.org/10.1371/journal.pone.0320509

Vancouver

Li M, Hu X, Hu X, Gao F, Cui Y, Wei X, et al. Inhibition of PHB1/PHB2 suppresses atherosclerotic plaque formation by interrupting PI3K/AKT/mTOR signaling. PLOS ONE. 2025. doi:10.1371/journal.pone.0320509

BibTeX
@article{Li2025,
  author = {Li, Mei and Hu, Xiaoyan and Hu, Xinxin and Gao, Fuhua and Cui, Ying and Wei, Xiaoqing and Qin, Yuanhua and An, Xiaohua and Zhao, Ying and Gao, Ying},
  title = {Inhibition of PHB1/PHB2 suppresses atherosclerotic plaque formation by interrupting PI3K/AKT/mTOR signaling},
  journal = {PLOS ONE},
  year = {2025},
  doi = {10.1371/journal.pone.0320509}
}
Kostenlos starten →